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a b s t r a c t
The cowpea chlorotic mottle virus (CCMV) is a nanoparticle that holds promise for diagnostic and
therapeutic applications. The empty virus-like particle, however, is not stable under physiological con-
ditions. Here, we describe a systematic study into the expansion of the assembly properties of a protein-
based block copolymer of the CCMV capsid protein and an elastin-like polypeptide. By systematically
changing the hydrophobicity of the stimulus-responsive elastin-like polypeptide block, assembly of the
capsid proteins could be achieved at close to physiological conditions. This strategy may prove to be
useful in the development of a physiologically stable CCMV capsid variant.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Nanoparticles are important tools in the development of diag-
nostic and therapeutic tests for applications in medicine. In
particular, virus-like particles (VLPs), i.e. viruses without their
endogenous genetic material, are interesting scaffolds.1 They are
biocompatible, as their building blocks are proteins, and mono-
disperse and well-defined, due to the fact that they are always built
up from a specific number of capsid proteins. In vivo studies on their
use as drug carriers and other applications have already been
performed, e.g. with the M13 bacteriophage, bacteriophage P22,
tobacco mosaic virus (TMV), potato virus X (PVX), and cowpea
mosaic virus (CPMV).2e5 Even though these types of VLPs show
great promise as imaging agents and drug delivery vehicles, they
lack flexibility with regard to their encapsulation and modification
properties, as they cannot be reversibly assembled and dis-
assembled. The capsid proteins of the cowpea chlorotic mottle virus
(CCMV), on the other hand, are able to reversibly assemble and
disassemble, without their genetic material being present. The
CCMV VLP assembles when the pH of the environment is lowered
to 5.0. This results in icosahedral capsids with T ¼ 3 symmetry and
inner and outer diameters of 18 and 28 nm, respectively.6,7 When
the pH is increased to 7.5, the capsids fall apart into capsid protein
dimers. These dimers arise from interdimer interactions, involving
the N- and C-termini of the capsid proteins.7 The reversible as-
sembly of CCMV capsids has previously been used to encapsulate
different types of cargoes, such as MRI contrast agents and
enzymes.8,9
Even though no toxicity has been observed after injection of
CCMV particles in mice, the capsids have not been applied
frequently for in vivo studies.10 This is due to the fact that, in order
for CCMV to be stable under physiological conditions, it has to be
held together by a negatively charged cargo polymer, e.g. nucleic
acids.10 Since this restricts the incorporation of a cargo, and thus the
application of CCMV in the medical field, we set out to improve the
stability of the CCMV capsid. More specifically, we would like to
expand the conditions under which empty CCMV VLPs can be
formed towards physiological conditions.
Previously, we developed a protein-based block copolymer of
the CCMV capsid protein and an elastin-like polypeptide (ELP).11
Elastin-like polypeptides are stimulus-responsive compounds,
derived from the naturally occurring, highly elastic protein
elastin.12 They consist of repeating Val-Pro-Gly-Xaa-Gly (VPGXP)
pentapeptides, where the guest residue Xaa/X can be any natural
amino acid except proline. ELPs can be reversibly switched from a
water-soluble state to a hydrophobic, collapsed state, in response to
changes in the environmental conditions, such as an increase in
temperature or salt concentration. The guest residue furthermore* Corresponding author.
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plays an important role in the transition process; a more hydro-
phobic amino acid will shift the transition temperature (Tt) to lower
values, whereas a more hydrophilic moiety will increase the Tt. A
short ELP, consisting of nine pentapeptide repeats, was attached to
the N-termini of CCMV capsid proteins, which are located in close
proximity to each other in the interior of the VLPs. By introducing
the ELPs, a new assembly pathway towards CCMV capsids was
introduced.11 T ¼ 3 VLPs could still be formed using pH-induced
assembly, whereas the new ELP-induced assembly pathway resul-
ted in smaller particles with T ¼ 1 icosahedral symmetry. The latter
pathway could be initiated by an increase in the environmental
temperature or salt concentration, leading to a higher local con-
centration of ELPs and subsequent assembly of the capsid proteins
towards ELP-CCMV VLPs.
The development of the ELP-CCMV construct improved the as-
sembly properties of the CCMV capsid protein such, that capsid
formation could be induced at pH 7.5. Even though this is closer to
physiologically relevant conditions, a high sodium chloride con-
centration (~2M)was still needed to induce capsid formation. Here,
we will introduce mutations in the guest residues of the short N-
terminal ELP, in order to render this more hydrophobic. This should
lead to ELP-CCMV constructs, which are able to assemble at lower
salt concentrations at pH 7.5. In order to understand the effect of
the mutations, these will be introduced in a systematic and
controlled way. In this way, we hope to establish whether the
switchable assembly behavior of the ELP-CCMV capsid proteins can
be controlled by the hydrophobicity of the ELP and might even be
predictable.
2. Results and discussion
In order to introduce more hydrophobic residues in the ELP of
the ELP-CCMV construct, we started with the native ELP-CCMV
construct: H6-ELP-CCMV(DN26). This construct has an N-terminal
hexahistidine tag for purification purposes, followed by an ELP
block, replacing the RNA binding domain of the wild-type CCMV
capsid protein. The native ELP sequence is VPGVG-VPGLG-VPGVG-
VPGLG-VPGVG-VPGLG-VPGGG-VPGVG-VPGLG, containing four
valine guest residues, four leucine guest residues, and one glycine
guest residue. In short, this ELP can be described using the general
notation ELP[V4L4G1-9], where all guest residues and their ratios
are given, followed by the total number of pentapeptide repeats.
We decided to target the valine and leucine residues andmutate
them to either tyrosines or tryptophans to introduce more hydro-
phobic residues in the ELP (Table 1). A valine to tyrosine mutation
can be done in the 1st position (first pentapeptide at the N-ter-
minus), 3rd position, 5th position, and 8th position. We decided to
compare a single mutation from valine to tyrosine on both the 1st
and 8th position (VY1 and VY8, respectively), to investigate
whether there would be a positional effect of the mutation.
Additionally, two or three valine to tyrosine mutations could give
information about the linearity of the effect of the hydrophobicity
of the guest residues and the assembly behavior of the ELP-CCMV
construct. To this end, we envisioned to make the VY1-VY8, and
VY1-VY5-VY8 mutants. To see if valine to tryptophan mutations
would have an even bigger effect, we also aimed at creating the
VW1, VW1-VW8, and VW1-VW5-VW8 mutants. Lastly, to confirm
the relationship between the hydrophobicity of the ELP and the
assembly behavior of ELP-CCMV, we also envisioned to mutate
leucine residues to more hydrophobic residues and compare these
constructs to the above-mentioned ones. To this end, we designed
LY2, LY9, and LW2 mutants.
In order to relate these ELPs in terms of hydrophobicity, we used
a hydrophobicity scale developed by Urry.13 Following this scale,
transition temperatures of each possible guest residue in an ELP
sequence were experimentally determined. Note that these Tt
values highly depend on the salt concentration of the buffer and the
concentration of the ELP itself. Nevertheless, we could use these
values to calculate a hydrophobicity factor of all proposed ELP-
CCMV mutants, by averaging the Tt's of all nine guest residues
(Table 1).
Next, we cloned all the designed constructs, starting from the
original H6-ELP[V4L4G1-9]-CCMV(DN26) vector. We envisioned to
use PCR driven mutagenesis to introduce the mutations in the 1st,
8th and 9th positions. All other guest residues could not bemutated
using this strategy, as the required primers would have exceeded a
length of 50 nucleotides. Not only would this have led to problems
due to secondary structure formation in the primers, but also the
chance of mismatches would have been high due the highly re-
petitive sequence of the ELP. Therefore, full-length DNA sequences
were ordered for LY2, LW2, VY1-VY5-VY8, and VW1-VW5-VW8
and annealed in the desired vector. All other constructs were
cloned, starting with PCR driven mutagenesis with the corre-
sponding primers, and annealed into the expression vector (see SI
for detailed experimental procedures).
After successful cloning of all ten ELP-CCMV mutants, we tested
whether these variants could be expressed in Escherichia coli
(E. coli). To this end, all vectors were transformed into BLR(DE3)
pLysS cells and small scale test expressions were performed.
Polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the ly-
sates confirmed IPTG-induced expression of seven of the mutants;
LW2, VY1-VY5-VY8, and VW1-VW5-VW8 had not been expressed
(Fig. S1). Subsequently, the remaining seven variants and native
ELP-CCMV were produced in a large scale expression, followed by
purification via Ni2þ affinity chromatography. SDS-PAGE and elec-
trospray ionization time-of-flight (ESI-TOF) mass spectrometry
analysis confirmed the successful expression of the proteins (see SI
for experimental procedures and characterization of the expressed
proteins).
In order to investigate the assembly behavior of the ELP-CCMV
variants, we set out to determine the salt concentration at which
each variant would start to assemble, at a certain concentration and
temperature. In our studies, we chose to vary the concentration of
sodium chloride and determine the transition NaCl concentration
at certain temperatures.
For the first experiments, the fluorescent molecular probe 8-
anilinonaphthalene-1-sulfonic acid (ANS) was used as a read-out
system for capsid assembly. The fluorescence intensity of this
probe increases when it binds to hydrophobic regions of proteins.
We used this dye to monitor the aggregation of the ELPs at certain
NaCl concentrations. A sudden increase of fluorescence intensity
could be linked to ELP aggregation, which is the driving force for
capsid assembly. This assay was used to determine the transition
NaCl concentration of native ELP-CCMV and the 7 variants thereof
at four different temperatures (see SI for the detailed experimental
Table 1
Overview of the ELP-CCMV variants designed for this study, along with their
calculated hydrophobicity factors.
Variant ELP guest residues Hydrophobicity factor13
Native VLVLVLGVL 19.9 C
LY2 VYVLVLGVL 11.0 C
LY9 VLVLVLGVY 11.0 C
VY1 YLVLVLGVL 8.7 C
VY8 VLVLVLGYL 8.7 C
LW2 VWVLVLGVL 7.7 C
VW1 WLVLVLGVL 5.3 C
VY1-VY8 YLVLVLGYL 2.6 C
VW1-VW8 WLVLVLGWL 9.2 C
VY1-VY5-VY8 YLVLYLGYL 13.8 C
VW1-VW5-VW8 WLVLWLGWL 23.8 C
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procedures). As a control, only buffer was added to the ANS dye; as
expected, for all NaCl concentrations ranging from 0.15 to 2.0M, the
same emission intensity wasmeasured in buffer (Fig. S2). For native
ELP-CCMV, LY2, LY9, VY1, and VY9, a clear transition NaCl con-
centration could be observed, where the emission maximum
stopped from being constant (Fig. S3). From this point on towards
higher NaCl concentrations, a linear increase in the emission
maximum was observed, corresponding to the continuous release
of water from the aggregated ELP structures. When the data
collected for each of these proteins at 20, 24, 28, and 32 C are
compared, a linear relationship between the transition NaCl con-
centration and the temperature was observed (Fig. 1A). When the
same data was plotted slightly differently, it could be observed that
there also seems to be a linear trend between the transition NaCl
concentration and the hydrophobicity factor of the ELP (Fig. 1B).
This indicates that the behavior of an ELP-CCMV construct is pre-
dictable, based on the hydrophobicity factor of the short N-terminal
ELP. This data also shows that there is a slight difference in the
behavior of LY2 and LY9, and of VY1 and VY8. In both cases, the
mutation at the C-terminal end of the ELP seems to have the
greatest effect on the assembly behavior of the ELP-CCMV
construct. This might be explained by the fact that a mutation
closer to the CCMV capsid protein will have more effect on its as-
sembly. Furthermore, it can be noted that there seems to be no clear
difference between a mutation of a leucine or valine residue; the
hydrophobicity factor of the ELP is most influential when it comes
to the resulting assembly behavior of the ELP-CCMV variant.
The behavior of the three most hydrophobic ELP-CCMV variants,
namely VW1, VY1-VY8 and VW1-VW8 could not be measured
under these experimental conditions. Instead of a sharp transition
in the fluorescence emission maximum, a very subtle increase in
the emission was observed going from 150 mM NaCl to 2000 mM
NaCl (Fig. S4). This indicates that these variants were already
assembled at 150 mM NaCl and that an increase in the NaCl con-
centration in this case only leads to loss of water from the aggre-
gated ELP core of the capsids.
In order to confirm that the increase in the emission maximum
observed in the ANS assay corresponds to a transition of ELP-CCMV
dimers to capsids, the assembly was further investigated using
dynamic light scattering (DLS) (see SI for the detailed experimental
procedures). In this case, DLS could be used to distinguish between
capsid protein dimers, which normally show a peak around 8 nm in
DLS distribution plots, and capsids, which are normally observed
around 20 nm in DLS distributions. Firstly, the assembly behavior of
ELP-CCMV variant LY2 was fully characterized at 20 C. In both the
intensity distribution (Fig. S5) and the number distribution (Fig. 2
and Fig. S6), dimers were observed at NaCl concentrations below
1500 mM. At 1500 mM NaCl and higher, capsids were visible. This
data therefore confirms that the ANS assay is indeed able to
distinguish between capsid protein dimers and capsids.
When the DLS data were compared to the data obtained in the
ANS assay, it was found that the transition NaCl concentrations
observed in the DLS distribution plots were consistently higher
than the transition NaCl concentrations determined by the ANS
assay. For LY2, a transition NaCl concentration of 1.23 M NaCl was
determined by the ANS assay at 20 C, whereas capsids were only
observed starting from 1.5 M in the DLS distribution plots. We
believe that the ANS assay is more sensitive to changes in hydro-
phobicity and the subsequent onset of assembly. Furthermore, the
experimental set-up of the ANS assay also allowed for more
controlled experimental conditions, such as temperature, incuba-
tion times, and waiting times in between measurements than the
DLS procedure. We therefore think that the ANS data are more
reliable than the DLS data. The trends with both techniques, how-
ever, are similar.
Fig. 1. Transition NaCl concentrations of native ELP-CCMV and four ELP-CCMV variants, measured using the ANS assay, at a final protein concentration of 20 mM. A) Transition NaCl
concentration plotted against the experimental temperature, per protein variant. B) Transition NaCl concentration plotted against the calculated hydrophobicity factor (Table 1), per
experimental temperature. The linear fits were added to help visualize the observed trends.
Fig. 2. Number distributions of LY2 ELP-CCMV at different NaCl concentrations, as
determined by DLS.
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Next, we also checked the behavior of native ELP-CCMV and
variants LY9, VY1-VY8, and VW1-VW8 using DLS (Fig. 3 and Fig. S7).
As expected, we observed a transition from dimers to capsids for
native and LY9 ELP-CCMV, going from 600 mM NaCl to 1700 mM
NaCl. For VY1-VY8 and VW1-VW8, we did not observe any transi-
tion in the ANS assay, which led us to suggest that these proteins
might be in the capsid state at all NaCl concentrations that were
tested. This was indeed confirmed by the DLS data measured at
150 mM and 1700 mM NaCl. For both these proteins, only capsids
and no dimers were observed at these NaCl concentrations.
3. Conclusions
Wehave described a systematic study into the effect of the guest
residues in the short N-terminal ELP sequence, attached to the
CCMV capsid protein. We found that the assembly behavior of the
capsid protein depends in a predictable, linear way on the hydro-
phobicity of the ELP. ELP-CCMV variants were developed which
could assemble at much lower NaCl concentrations than the native
ELP-CCMV capsid protein. These results allow the construction of
ELP-CCMV proteins which have the desired switchable assembly
behavior. In our lab, studies are ongoing to find out whether the
systematic variations in the ELP-CCMV construct can be applied to
produce physiologically stable ELP-CCMV capsids.
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